Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery - PubMed (original) (raw)

. 2007 Oct 1;343(1-2):48-58.

doi: 10.1016/j.ijpharm.2007.04.019. Epub 2007 Apr 27.

Affiliations

• PMID: 17544606
• DOI: 10.1016/j.ijpharm.2007.04.019

Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery

Krum Kafedjiiski et al. Int J Pharm. 2007.

Abstract

It was the aim of this study to synthesize and characterize a novel hyaluronic acid-cysteine ethyl ester (HA-Cys) conjugate providing improved mucoadhesive properties and a significantly lowered biodegradation rate. Mediated by carbodiimide and N-hydroxysuccinimide, L-cysteine ethyl ester hydrochloride was covalently attached to hyaluronic acid (HA, hyaluronan) via the formation of an amide bond. The adhesive properties of HA-Cys conjugates were evaluated in vitro on a freshly excised porcine mucosa via the rotating cylinder method. The cohesive properties of the resulting conjugates were evaluated by oxidation experiments. Biodegradability studies were carried out by viscosity measurements and spectrophotometric assays. Release studies were performed with fluorescein isothiocyanate-dextrans (FD) as model compounds. The obtained conjugate displayed 201.3+/-18.7 micromol immobilized free thiol groups and 85.7+/-22.3 micromol disulfide bonds per gram polymer. Results from the rotating cylinder method showed more than 6.5-fold increase in the adhesion time of HA-Cys versus unmodified HA. In aqueous solutions, the obtained conjugate demonstrated improved cohesive properties. The hydrolysis degree of HA-Cys was lower compared with the corresponding unmodified HA in the framework of viscosity experiments. In addition, the cross-linking process via disulfide bonds additionally reduced the rate of degradation of the new derivative. Cumulative release studies out of matrix tablets comprising HA-Cys and the model compound FD demonstrated a sustained drug release for more than 12h due to in situ formation of inter- and intramolecular disulfide bonds in the thiomer matrix. According to the results of the present study, this novel thiolated polymer seems to represent a promising multifunctional excipient for the development of various drug delivery systems.

PubMed Disclaimer

Similar articles

• Synthesis and in vitro evaluation of a novel thiolated chitosan.
  Kafedjiiski K, Krauland AH, Hoffer MH, Bernkop-Schnürch A. Kafedjiiski K, et al. Biomaterials. 2005 Mar;26(7):819-26. doi: 10.1016/j.biomaterials.2004.03.011. Biomaterials. 2005. PMID: 15350788
• Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
  Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A. Kafedjiiski K, et al. Biomaterials. 2006 Jan;27(1):127-35. doi: 10.1016/j.biomaterials.2005.05.075. Biomaterials. 2006. PMID: 16045983
• Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate.
  Schmitz T, Grabovac V, Palmberger TF, Hoffer MH, Bernkop-Schnürch A. Schmitz T, et al. Int J Pharm. 2008 Jan 22;347(1-2):79-85. doi: 10.1016/j.ijpharm.2007.06.040. Epub 2007 Jun 30. Int J Pharm. 2008. PMID: 17681439
• Thiomers: potential excipients for non-invasive peptide delivery systems.
  Bernkop-Schnürch A, Krauland AH, Leitner VM, Palmberger T. Bernkop-Schnürch A, et al. Eur J Pharm Biopharm. 2004 Sep;58(2):253-63. doi: 10.1016/j.ejpb.2004.03.032. Eur J Pharm Biopharm. 2004. PMID: 15296953 Review.
• Thiomers for oral delivery of hydrophilic macromolecular drugs.
  Bernkop-Schnürch A, Hoffer MH, Kafedjiiski K. Bernkop-Schnürch A, et al. Expert Opin Drug Deliv. 2004 Nov;1(1):87-98. doi: 10.1517/17425247.1.1.87. Expert Opin Drug Deliv. 2004. PMID: 16296722 Review.

Cited by

• Hyaluronic acid enhances the mechanical properties of tissue-engineered cartilage constructs.
  Levett PA, Hutmacher DW, Malda J, Klein TJ. Levett PA, et al. PLoS One. 2014 Dec 1;9(12):e113216. doi: 10.1371/journal.pone.0113216. eCollection 2014. PLoS One. 2014. PMID: 25438040 Free PMC article.
• Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.
  Soiberman U, Kambhampati SP, Wu T, Mishra MK, Oh Y, Sharma R, Wang J, Al Towerki AE, Yiu S, Stark WJ, Kannan RM. Soiberman U, et al. Biomaterials. 2017 May;125:38-53. doi: 10.1016/j.biomaterials.2017.02.016. Epub 2017 Feb 16. Biomaterials. 2017. PMID: 28226245 Free PMC article.
• Development of biodegradable methylprednisolone microparticles for treatment of articular pathology using a spray-drying technique.
  Tobar-Grande B, Godoy R, Bustos P, von Plessing C, Fattal E, Tsapis N, Olave C, Gómez-Gaete C. Tobar-Grande B, et al. Int J Nanomedicine. 2013;8:2065-76. doi: 10.2147/IJN.S39327. Epub 2013 May 27. Int J Nanomedicine. 2013. PMID: 23737670 Free PMC article.
• Formulation and Characterization of Native and Crosslinked Hyaluronic Acid Microspheres for Dermal Delivery of Sodium Ascorbyl Phosphate: A Comparative Study.
  Fallacara A, Marchetti F, Pozzoli M, Citernesi UR, Manfredini S, Vertuani AS. Fallacara A, et al. Pharmaceutics. 2018 Dec 1;10(4):254. doi: 10.3390/pharmaceutics10040254. Pharmaceutics. 2018. PMID: 30513791 Free PMC article.
• Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response.
  Le X, Poinern GE, Ali N, Berry CM, Fawcett D. Le X, et al. Int J Biomater. 2013;2013:782549. doi: 10.1155/2013/782549. Epub 2013 Feb 27. Int J Biomater. 2013. PMID: 23533416 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database